Association of primary tumor radiomic phenotypes and outcomes in patients (pts) with metastatic renal cell clear cell carcinoma (mRCC) treated with cytoreductive nephrectomy (CN).

被引：0
|
作者：
Cunha, Mateus Trinconi
Stangler, Lucas
Freire, Pedro
Alves Pinto, Paulo Victor
Almeida Coelho, Fernando Morbeck
Viana, Publio
Cordeiro, Mauricio
Nahas, William Carlos
Mota, Jose Mauricio
机构：
[1] Univ Sao Paulo, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[2] Univ Sao Paulo, Inst Radiol, Sao Paulo, Brazil
[3] Univ Sao Paulo, Dept Radiol, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[4] Univ Sao Paulo, Dept Urol, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
622
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Survival outcomes following cytoreductive nephrectomy (CN) in patients with metastatic renal cell sarcomas (MRCS).
    Malla, Midhun
    Johnston, Sarah E.
    Zhao, Yan D.
    Pareek, Vipul
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Sites of metastasis (mets) and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
    Martini, Dylan J.
    Shabto, Julie M.
    Liu, Yuan
    Carthon, Bradley Curtis
    Speak, Alexandra
    Hitron, Elise
    Russler, Greta
    Caulfield, Sarah
    Ogan, Kenneth
    Harris, Wayne
    Master, Viraj A.
    Kucuk, Omer
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [33] NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy
    Liu, Huanrui
    Li, Senlin
    Zhang, Fan
    He, Weiyang
    Gou, Xin
    Zhang, Xu
    Xie, Yongpeng
    BIOMARKERS IN MEDICINE, 2025,
  • [34] NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy
    Liu, Huanrui
    Li, Senlin
    Zhang, Fan
    He, Weiyang
    Gou, Xin
    Zhang, Xu
    Xie, Yongpeng
    BIOMARKERS IN MEDICINE, 2025, 19 (06) : 215 - 222
  • [35] CABOPRE: Phase II study of cabozantinib prior to cytoreductive nephrectomy (CN) in locally advanced and/or metastatic renal cell carcinoma (mRCC).
    de Velasco, Guillermo
    Gonzalez, Borja
    Alonso, Teresa
    Pinto, Alvaro
    Francisco Rodriguez-Moreno, Juan
    Manuel Sepulveda, Juan
    Carlos Villa, Jose
    Miranda, Natalia
    Guerrero, Felix
    Castellano, Daniel E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] Temporal trends and socioeconomic determinants of cytoreductive nephrectomy (CN) utilization for metastatic renal cell carcinoma (mRCC) in the United States (US).
    Esagian, Stepan M.
    Msaouel, Pavlos
    Karam, Jose A.
    Gartrell, Benjamin
    Makrakis, Dimitrios
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [37] Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non-clear Cell Renal Cell Carcinoma Patients
    Luzzago, Stefano
    Palumbo, Carlotta
    Rosiello, Giuseppe
    Knipper, Sophie
    Pecoraro, Angela
    Mistretta, Francesco Alessandro
    Tian, Zhe
    Musi, Gennaro
    Montanari, Emanuele
    Soulieres, Denis
    Shariat, Shahrokh F.
    Saad, Fred
    Briganti, Alberto
    de Cobelli, Ottavio
    Karakiewicz, Pierre I.
    EUROPEAN UROLOGY FOCUS, 2021, 7 (03): : 598 - 607
  • [38] The role of cytoreductive nephrectomy (CN) for patients with metastatic renal cell carcinoma (mRCC) in the setting of retroperitoneal lymphadenopathy: An analysis of the National Cancer Database (NCDB)
    Reddy, Akshay
    Sparks, Andrew D.
    Whalen, Michael Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [39] Immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib (EORTC 30073 SURTIME)
    Bex, A.
    Mulders, P.
    Jewett, M. A. S.
    Wagstaff, J.
    van Velthoven, R.
    Pes, P. M. Laguna
    Wood, L.
    van Melick, H. H. E.
    Soetekouw, P.
    Lattouf, J. B.
    Powles, T.
    Boleti, E.
    de Jong, I-J.
    Rottey, S.
    Tombal, B.
    Marreaud, S.
    Collette, L.
    Collette, S.
    Blank, C. U.
    Haanen, J. B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm
    Tappero, Stefano
    Barletta, Francesco
    Piccinelli, Mattia Luca
    Garcia, Cristina Cano
    Incesu, Reha-Baris
    Morra, Simone
    Scheipner, Lukas
    Tian, Zhe
    Parodi, Stefano
    Dell'Oglio, Paolo
    Palumbo, Carlotta
    Briganti, Alberto
    De Cobelli, Ottavio
    Chun, Felix K. H.
    Graefen, Markus
    Longo, Nicola
    Ahyai, Sascha
    Saad, Fred
    Shariat, Shahrokh F.
    Suardi, Nazareno
    Borghesi, Marco
    Terrone, Carlo
    Karakiewicz, Pierre I.
    EUROPEAN UROLOGY FOCUS, 2023, 9 (05): : 742 - 750
12345